Caveney Brian J 4
Research Summary
AI-generated summary
Labcorp (LH) EVP Brian Caveney Receives RSUs; Shares Withheld
What Happened
- Brian J. Caveney, EVP and President of ED (also CMO & CSO) at Labcorp Holdings (LH), had restricted stock units (RSUs) convert to common shares on Feb 6–7, 2026. A total of 1,298 RSUs vested/converted into shares. To satisfy tax obligations, 389 of those shares were withheld (disposed) in stock withholding transactions, totaling about $107,256. After withholding, Caveney received a net ~909 shares.
- These were vesting/conversion events (derivative/RSU transactions), not open-market buys or sales. The withholding is a routine tax-payment method, not a discretionary sale.
Key Details
- Transaction dates: RSU conversion on 2026-02-06 (670 shares) and 2026-02-07 (517 + 111 shares); tax-withholding/stock surrender on 2026-02-06 (209 shares at $277.20 = $57,935) and 2026-02-09 (148 + 32 shares at $274.01 = $49,321; combined = $40,553 + $8,768 = $49,321). Total withheld value ≈ $107,256.
- Net shares issued to insider after withholding: ~909 shares (1,298 converted − 389 withheld).
- Footnotes: F1 = each RSU converts to one share; F3 = stock withholding used to satisfy tax obligations; F4/F6 = vesting schedules (these RSUs vested per grant terms).
- Filing: Form filed Feb 10, 2026 reporting transactions through Feb 6–9, 2026. (The filing shows the conversion and withholding events; it does not represent an open-market sale or a discretionary purchase.)
Context
- This was a vesting/conversion of restricted stock units with shares surrendered to cover taxes (a cashless/withholding routine). Such withholding transactions are administrative and common when equity awards vest and typically do not signal the insider taking a market view for buying/selling.